Table 5 presents the comparison of the MFI between groups of patients with squamous cell carcinoma and volunteers used to evaluate the expression of subtypes of immune system cells and the activation marker CD69 in these cells. This evidence concerns the gene CD69 and squamous cell carcinoma.